Ropes & Gray advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics (Nasdaq: GLUE) has entered into a global exclusive licensing agreement with Novartis to...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here